Association between hospital racial composition and aortic valve replacement outcomes: A national inpatients sample database analysis
Catheterization and Cardiovascular Interventions · 2024
DOI: 10.1002/ccd.30970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Yanfei Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of International Business, China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Heart Valve Prosthesis Implantation, Acute Kidney Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Background
Racial and ethnic disparities exist in the outcomes following surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI). However, it is unclear whether hospital racial composition contributes to these racial disparities.
Methods
We analyzed the National Inpatient Sample (NIS) database from 2015 to 2019 to identify patients with aortic stenosis (AS) who received SAVR and TAVI. The Racial/Ethnic Diversity Index (RDI) was used to assess hospital racial composition as the proportion of nonwhite patients to total hospital admissions. Hospitals were categorized into RDI quintiles. Textbook outcome (TO) was defined as no in‐hospital mortality, no postoperative complications and no prolonged length of stay (LOS). Multivariable mixed generalized linear models were conducted to assess the association between RDI and post‐SAVR and post‐TAVI outcomes. Moreover, quantile regression was used to assess the additional cost and length of stay associated with the RDI quintile.
Results
The study included 82,502 SAVR or TAVI performed across 3285 hospitals, with 47.4% isolated SAVR and 52.5% isolated TAVI. After adjustment, quintiles 4 and 5 demonstrated significantly lower odds of TO than the lowest RDI quintile in both the SAVR cohort (quintile 4, 0.79 [95% CI, 0.73–0.85]; quintile 5, 0.79 [95% CI, 0.73–0.86]) and TAVI cohort (quintile 4, 0.88 [95% CI, 0.82–0.95]; quintile 5, 0.80 [95% CI, 0.74–0.86]). Despite non‐observable differences in in‐hospital mortality across all RDI quintiles, the rate of AKI and blood transfusion increased with increasing RDI for both cohorts. Further, Higher RDI quintiles were associated with increased costs and longer LOS. From 2015 to 2019, post‐TAVI outcomes improved across all RDI quintiles.
Conclusions
Hospitals with a higher RDI experienced lower TO achievements, increased AKI, and blood transfusion, along with extended LOS and higher costs. Importantly, post‐TAVI outcomes improved from 2015 to 2019 across all RDI groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of International Business, China Pharmaceutical University, Nanjing, China.
- Department of Thoracic and Cardiovascular Surgery, Nanjing Medical University, Nanjing, China.
- Immunization Center, Ningbo Municipal Centre for Disease Control and Prevention, Ningbo, China.
ORCID-Profile: Yanfei Chen, Jifang Zhou
Zitieren
APA
Chen, Y., Xiao, Y., Huang, R., Jiang, F., Zhou, J., Su, C., & Yang, T. (2024). Association between hospital racial composition and aortic valve replacement outcomes: A national inpatients sample database analysis. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30970
Vancouver
Chen Y, Xiao Y, Huang R, Jiang F, Zhou J, Su C, et al. Association between hospital racial composition and aortic valve replacement outcomes: A national inpatients sample database analysis. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.30970
BibTeX
@article{Chen2024,
author = {Chen, Yanfei and Xiao, Yue and Huang, Ruijian and Jiang, Feng and Zhou, Jifang and Su, Cunhua and Yang, Tianchi},
title = {Association between hospital racial composition and aortic valve replacement outcomes: A national inpatients sample database analysis},
journal = {Catheterization and Cardiovascular Interventions},
year = {2024},
doi = {10.1002/ccd.30970}
}
EUVIMED